BioRem Dividends and Buybacks

Dividend criteria checks 0/6

BioRem does not have a record of paying a dividend.

Key information

n/a

Dividend yield

Buyback Yield

Total Shareholder Yield	0%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if BRM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BRM's dividend payments have been increasing.

Dividend Yield vs Market

BioRem Dividend Yield vs Market

How does BRM dividend yield compare to the market?
Segment	Dividend Yield
Company (BRM)	n/a
Market Bottom 25% (CA)	1.8%
Market Top 25% (CA)	6.2%
Industry Average (Commercial Services)	0.7%
Analyst forecast (BRM) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate BRM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BRM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate BRM's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as BRM has not reported any payouts.

BioRem Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

BIOREM Inc. (TSXV:BRM) announces an Equity Buyback for 23,434,121 shares, for CAD 12.32 million.

Recent updates

Investor sentiment improves as stock rises 27%

Third quarter 2024 earnings released: EPS: CA$0.14 (vs CA$0.032 in 3Q 2023)

Investors Continue Waiting On Sidelines For BioRem Inc. (CVE:BRM)

Second quarter 2024 earnings released: EPS: CA$0.021 (vs CA$0.006 loss in 2Q 2023)

First quarter 2024 earnings released: EPS: CA$0.022 (vs CA$0.036 loss in 1Q 2023)

Solid Earnings May Not Tell The Whole Story For BioRem (CVE:BRM)

BioRem Inc., Annual General Meeting, Jun 04, 2024

BioRem Inc. (CVE:BRM) Soars 35% But It's A Story Of Risk Vs Reward

Full year 2023 earnings released: EPS: CA$0.14 (vs CA$0.10 in FY 2022)

BioRem (CVE:BRM) Has A Pretty Healthy Balance Sheet

Investor sentiment improves as stock rises 39%

Third quarter 2023 earnings released: EPS: CA$0.03 (vs CA$0.049 in 3Q 2022)

Insufficient new directors

Is BioRem (CVE:BRM) Using Too Much Debt?

New minor risk - Share price stability

Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.011 profit in 2Q 2022)

Insufficient new directors

Investor sentiment improves as stock rises 20%

First quarter 2023 earnings released: CA$0.036 loss per share (vs CA$0.007 loss in 1Q 2022)

Full year 2022 earnings released: EPS: CA$0.10 (vs CA$0.036 in FY 2021)

Here's Why BioRem (CVE:BRM) Can Manage Its Debt Responsibly

Third quarter 2022 earnings released: EPS: CA$0.05 (vs CA$0.003 loss in 3Q 2021)

BioRem (CVE:BRM) Could Easily Take On More Debt

Second quarter 2022 earnings released: EPS: CA$0.011 (vs CA$0.007 in 2Q 2021)

First quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 1Q 2021)

These 4 Measures Indicate That BIOREM (CVE:BRM) Is Using Debt Reasonably Well

BIOREM Inc., Annual General Meeting, Jun 14, 2022

Full year 2021 earnings released: EPS: CA$0.036 (vs CA$0.054 in FY 2020)

Here's What's Concerning About BIOREM's (CVE:BRM) Returns On Capital

Third quarter 2021 earnings: Revenues in line with analyst expectations

BIOREM Inc. (TSXV:BRM) announces an Equity Buyback for 23,434,121 shares, for CAD 12.32 million.

High number of new directors

Second quarter 2021 earnings released: EPS CA$0.007 (vs CA$0.009 in 2Q 2020)

High number of new directors

First quarter 2021 earnings released: EPS CA$0.01 (vs CA$0.01 in 1Q 2020)

Full year 2020 earnings released: EPS CA$0.05 (vs CA$0.034 loss in FY 2019)

BIOREM Inc.(TSXV:BRM) dropped from S&P/TSX Venture Composite Index

New 90-day high: CA$0.64

BIOREM Inc. Announces Research Project with City of New York to Control Release of Bioaerosols from Waste Water Treatment Facilities

New 90-day high: CA$0.58

BIOREM Inc. Announces Successful Demonstration Projects Assessing Novel Biological Processes for the Mitigation of Industrial VOC Emissions

Key Things To Understand About BIOREM's (CVE:BRM) CEO Pay Cheque

New 90-day high - CA$0.39

Earnings released

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies